bullish

Ecovyst

ECVT: Regenerating Free Cash Flow

254 Views05 Nov 2022 00:35
Sulfuric acid sales are a pass-through causing sales to be lumpy, which is why ECVT reduced its sales outlook for 2022. However, adjusted EBITDA is now forecast towards the high end of the range
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
BWS Financial Inc
Independent Stock Specific Research
Equities
Price Chart(Sign Up to Access)
analytics-chart
x